399 related articles for article (PubMed ID: 8855827)
1. The effect on the insulin-like growth factor system in human prostate epithelial cells of immortalization and transformation by simian virus-40 T antigen.
Plymate SR; Tennant M; Birnbaum RS; Thrasher JB; Chatta G; Ware JL
J Clin Endocrinol Metab; 1996 Oct; 81(10):3709-16. PubMed ID: 8855827
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional regulation of insulin-like growth factor-I receptor gene expression in prostate cancer cells.
Damon SE; Plymate SR; Carroll JM; Sprenger CC; Dechsukhum C; Ware JL; Roberts CT
Endocrinology; 2001 Jan; 142(1):21-7. PubMed ID: 11145562
[TBL] [Abstract][Full Text] [Related]
3. Reexpression of the type 1 insulin-like growth factor receptor inhibits the malignant phenotype of simian virus 40 T antigen immortalized human prostate epithelial cells.
Plymate SR; Bae VL; Maddison L; Quinn LS; Ware JL
Endocrinology; 1997 Apr; 138(4):1728-35. PubMed ID: 9075737
[TBL] [Abstract][Full Text] [Related]
4. Characterization of insulin-like growth factor-binding protein-related proteins (IGFBP-rPs) 1, 2, and 3 in human prostate epithelial cells: potential roles for IGFBP-rP1 and 2 in senescence of the prostatic epithelium.
López-Bermejo A; Buckway CK; Devi GR; Hwa V; Plymate SR; Oh Y; Rosenfeld RG
Endocrinology; 2000 Nov; 141(11):4072-80. PubMed ID: 11089538
[TBL] [Abstract][Full Text] [Related]
5. Type-1 insulin-like growth factor receptor reexpression in the malignant phenotype of SV40-T-immortalized human prostate epithelial cells enhances apoptosis.
Plymate SS; Bae VL; Maddison L; Quinn LS; Ware JL
Endocrine; 1997 Aug; 7(1):119-24. PubMed ID: 9449047
[TBL] [Abstract][Full Text] [Related]
6. The role of insulin-like growth factor-II in cancer growth and progression evidenced by the use of ribozymes and prostate cancer progression models.
Guo N; Ye JJ; Liang SJ; Mineo R; Li SL; Giannini S; Plymate SR; Sikes RA; Fujita-Yamaguchi Y
Growth Horm IGF Res; 2003 Feb; 13(1):44-53. PubMed ID: 12550081
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins in primary cultures of prostate epithelial cells.
Cohen P; Peehl DM; Lamson G; Rosenfeld RG
J Clin Endocrinol Metab; 1991 Aug; 73(2):401-7. PubMed ID: 1713219
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) is a potential tumor suppressor protein for prostate cancer.
Sprenger CC; Damon SE; Hwa V; Rosenfeld RG; Plymate SR
Cancer Res; 1999 May; 59(10):2370-5. PubMed ID: 10344746
[TBL] [Abstract][Full Text] [Related]
9. Characterization of insulin-like growth factor-binding protein-related protein-1 in prostate cells.
Hwa V; Tomasini-Sprenger C; Bermejo AL; Rosenfeld RG; Plymate SR
J Clin Endocrinol Metab; 1998 Dec; 83(12):4355-62. PubMed ID: 9851777
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor suppresses insulin-like growth factor binding protein 3 levels in human papillomavirus type 16-immortalized cervical epithelial cells and thereby potentiates the effects of insulin-like growth factor 1.
Hembree JR; Agarwal C; Eckert RL
Cancer Res; 1994 Jun; 54(12):3160-6. PubMed ID: 7515765
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor axis abnormalities in prostatic stromal cells from patients with benign prostatic hyperplasia.
Cohen P; Peehl DM; Baker B; Liu F; Hintz RL; Rosenfeld RG
J Clin Endocrinol Metab; 1994 Nov; 79(5):1410-5. PubMed ID: 7525636
[TBL] [Abstract][Full Text] [Related]
12. Autocrine regulation of cell proliferation by the insulin-like growth factor (IGF) and IGF binding protein-3 protease system in a human prostate carcinoma cell line (PC-3).
Angelloz-Nicoud P; Binoux M
Endocrinology; 1995 Dec; 136(12):5485-92. PubMed ID: 7588299
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factors stimulate the release of insulin-like growth factor-binding protein-3 (IGFBP-3) and degradation of IGFBP-4 in nonsmall cell lung cancer cell lines.
Noll K; Wegmann BR; Havemann K; Jaques G
J Clin Endocrinol Metab; 1996 Jul; 81(7):2653-62. PubMed ID: 8675593
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor (IGF)-I, IGF-II and IGF type I receptor (IGFR-I) expression in prostatic cancer.
Cardillo MR; Monti S; Di Silverio F; Gentile V; Sciarra F; Toscano V
Anticancer Res; 2003; 23(5A):3825-35. PubMed ID: 14666684
[TBL] [Abstract][Full Text] [Related]
15. Regulation of insulin-like growth factor binding protein-3 messenger ribonucleic acid expression by insulin-like growth factor I.
Bale LK; Conover CA
Endocrinology; 1992 Aug; 131(2):608-14. PubMed ID: 1379162
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor binding protein-3 induces early apoptosis in malignant prostate cancer cells and inhibits tumor formation in vivo.
Devi GR; Sprenger CC; Plymate SR; Rosenfeld RG
Prostate; 2002 May; 51(2):141-52. PubMed ID: 11948969
[TBL] [Abstract][Full Text] [Related]
17. Androgen receptor (AR) expression in AR-negative prostate cancer cells results in differential effects of DHT and IGF-I on proliferation and AR activity between localized and metastatic tumors.
Plymate SR; Tennant MK; Culp SH; Woodke L; Marcelli M; Colman I; Nelson PS; Carroll JM; Roberts CT; Ware JL
Prostate; 2004 Nov; 61(3):276-90. PubMed ID: 15368471
[TBL] [Abstract][Full Text] [Related]
18. Secretion of insulin-like growth factors and their binding proteins by human normal and hyperplastic prostatic cells in primary culture.
Boudon C; Rodier G; Lechevallier E; Mottet N; Barenton B; Sultan C
J Clin Endocrinol Metab; 1996 Feb; 81(2):612-7. PubMed ID: 8636277
[TBL] [Abstract][Full Text] [Related]
19. Altered growth and insulin-like growth factor-binding protein-3 production in PC3 prostate carcinoma cells stably transfected with a constitutively active androgen receptor complementary deoxyribonucleic acid.
Marcelli M; Haidacher SJ; Plymate SR; Birnbaum RS
Endocrinology; 1995 Mar; 136(3):1040-8. PubMed ID: 7532576
[TBL] [Abstract][Full Text] [Related]
20. Alteration of the insulin-like growth factor axis during in vitro differentiation of the human osteosarcoma cell line HOS 58.
Viereck V; Siggelkow H; Pannem R; Braulke T; Scharf JG; Kübler B
J Cell Biochem; 2007 Sep; 102(1):28-40. PubMed ID: 17372931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
